Moreover, our data emphasize HOTAIR as a predictor of R-CHOP failure and GAS5 as a good indicator for R-CHOP overall response in DLBCL and highlight some target genes relating them to drug resistance, which need further validation. The gene discussed is GAS5; the disease is diffuse large B-cell lymphoma.